norketamine has been researched along with Depression in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, K; Luo, A; Yang, C; Yang, J | 1 |
| Ago, Y; Chen, L; Hashimoto, H; Hashimoto, K; Higuchi, M; Kasai, A; Naito, M; Nakagawa, S; Nakazawa, T; Seiriki, K; Tanabe, W; Tsukada, S; Yamaguchi, T; Yokoyama, R | 1 |
| Hashimoto, K | 1 |
| Huang, C; Jiang, R; Liu, C; Wang, Y; Wu, Z; Xu, J; Yan, E; Yang, C; Yang, L; Zhou, L; Zhu, B | 1 |
| Hashimoto, K; Shirayama, Y | 1 |
| Chaki, S; Dong, C; Han, M; Hashimoto, K; Kobayashi, S; Ma, M; Manabe, T; Nakao, K; Nakazawa, K; Qu, Y; Ren, Q; Shirayama, Y; Toki, H; Yamaguchi, JI; Yang, C; Zhang, JC | 1 |
| Hashimoto, K; Yang, C | 1 |
| Liu, J; Osgood, SM; Shaffer, CL; Smith, DL; Trapa, PE | 1 |
| Brutsche, N; Diazgranados, N; Franco-Chaves, J; Henter, ID; Ibrahim, L; Kronstein, P; Luckenbaugh, DA; Manji, HK; Moaddel, R; Wainer, I; Zarate, CA | 1 |
2 review(s) available for norketamine and Depression
| Article | Year |
|---|---|
Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Depression; Disease Models, Animal; Hippocampus; Humans; Ketamine; Prefrontal Cortex; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Stress, Psychological | 2019 |
Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine.
Topics: Animals; Antidepressive Agents; Brain; Brain-Derived Neurotrophic Factor; Depression; Gastrointestinal Microbiome; Humans; Ketamine; Receptors, N-Methyl-D-Aspartate; Spleen | 2020 |
1 trial(s) available for norketamine and Depression
| Article | Year |
|---|---|
Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Depression; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Ketamine; Male; Middle Aged; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Riluzole; Time Factors; Young Adult | 2012 |
6 other study(ies) available for norketamine and Depression
| Article | Year |
|---|---|
(S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression.
Topics: Anhedonia; Animals; Antidepressive Agents; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Female; Ketamine; Locomotion; Male; Mice; Mice, Inbred C57BL; Receptors, N-Methyl-D-Aspartate | 2020 |
Gut microbiota is involved in the antidepressant-like effect of (S)-norketamine in an inflammation model of depression.
Topics: Animals; Antidepressive Agents; Bacteria; Depression; Disease Models, Animal; Gastrointestinal Microbiome; Inflammation; Ketamine; Lipopolysaccharides; Locomotion; Male; Mice; Mice, Inbred C57BL; Receptors, N-Methyl-D-Aspartate | 2021 |
Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-Ketamine.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Excitatory Amino Acid Antagonists; Helplessness, Learned; Ketamine; Male; Off-Label Use; Rats; Spermidine; Time Factors | 2018 |
AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Dendritic Spines; Depression; Hippocampus; Ketamine; Mice; Mice, Inbred C57BL; Prefrontal Cortex; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Stress, Psychological | 2018 |
Is (S)-norketamine an alternative antidepressant for esketamine?
Topics: Animals; Antidepressive Agents; Depression; Humans; Ketamine | 2019 |
Enhancing ketamine translational pharmacology via receptor occupancy normalization.
Topics: Animals; Depression; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Ketamine; Macaca fascicularis; Male; Memory; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Species Specificity; Tritium | 2014 |